99mTc-Sestamibi

DIAGNOSTIC_TEST2 trials

Sponsors

Cell>Point LLC, Central Hospital, Nancy, France

Conditions

Coronary Artery DiseaseMyocardial Perfusion

Phase 2

Efficacy and Saftey Study of 99mTc-ECDG in the Evaluation of Coronary Artery Disease (CAD)

Not yet recruitingNCT01899833

Cell>Point LLCCoronary Artery Disease

Start: 2025-05-10End: 2026-04-30Target: 60Updated: 2025-04-01

Unknown Phase

Stress and Rest Myocardial Tomoscintigraphies Using Mono- or Double-isotope Protocol With a Semiconductor Camera

CompletedNCT02869126

Central Hospital, Nancy, FranceMyocardial Perfusion

Start: 2012-09-30End: 2015-11-30Updated: 2016-08-16